FORUSALL LIMITED
Company number 12861549 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
FORUSALL LIMITED - Analysis Report
Company Number: 12861549
Analysis Date: 2025-07-29 18:46 UTC
Financial Health Assessment of FORUSALL LIMITED as at 31 October 2024
1. Financial Health Score: B
Explanation:
FORUSALL LIMITED demonstrates solid improvement in its financial position over recent years. The company has moved from a net current liability position in 2020 to a healthy net current asset position in 2024, with positive shareholders’ funds increasing significantly. While the absolute size of the business remains small (micro entity), the upward trend in working capital and equity indicates growing financial stability and resilience. This earns a "B" grade, reflecting good financial health with room for continued strengthening.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £72 | Very low fixed asset base, typical for micro companies with minimal capital investment. |
| Current Assets | £13,514 | Healthy level of current assets, more than doubling since 2020, indicating improved liquidity. |
| Current Liabilities | £4,816 | Manageable short-term obligations, slightly increased but well covered by current assets. |
| Net Current Assets | £8,698 | Positive working capital ("healthy cash flow buffer") supports smooth operations. |
| Total Assets less Current Liabilities | £8,770 | Indicates overall net assets available after covering short-term debts. |
| Shareholders’ Funds | £8,770 | Positive equity, showing retained earnings and capital injections have strengthened the balance sheet. |
3. Diagnosis: What the Financial Data Reveals About Business Health
Liquidity & Working Capital:
The company’s liquidity has improved markedly, from a net current liability of -£2,719 in 2020 to a net current asset position of £8,698 in 2024. This suggests the company has alleviated its "cash flow strain" symptoms and now maintains a healthy cash flow buffer to meet upcoming obligations without distress.Balance Sheet Strength:
The growth in shareholders’ funds from a negative position in 2020 to £8,770 in 2024 signifies strengthening of the company’s financial "immune system." This improvement could be due to retained profits, capital injections, or better management of liabilities.Asset Base:
The very low fixed assets highlight a likely service-oriented or intellectual property-based business model typical in "Other engineering activities" (SIC 71129). The low capital intensity means less risk from asset impairments but also less collateral for borrowing.Company Size and Activity:
Classified as a micro-entity with only 2 employees, this is a small-scale operation with modest financial complexity. The steady growth in current assets and equity indicates the business is "recovering well" and expanding carefully.Filing and Compliance:
The company is up to date with accounts and confirmation statement filings, indicating good governance "vital signs."
4. Recommendations: Specific Actions to Improve Financial Wellness
Maintain and Monitor Liquidity:
Continue to build cash reserves and monitor working capital to ensure the company can comfortably handle short-term obligations, especially as the business grows.Profitability Focus:
Although profit/loss data is not provided, enhancing operational profitability will be essential to sustain and grow shareholders’ funds, acting as the company’s "nutritional intake" for future health.Diversify Asset Base:
Consider investing in strategic fixed assets or intellectual property to enhance competitive advantage and potential borrowing capacity, but avoid over-leveraging.Financial Planning and Forecasting:
Implement regular financial forecasting to detect early signs of distress (e.g., cash flow shortages), akin to preventive health screenings.Evaluate Growth Opportunities:
With improving financial strength, cautiously explore growth initiatives that align with core competencies to improve turnover and operational scale.Governance and Controls:
Maintain robust internal controls and compliance to avoid regulatory "infections" such as penalties or reputational damage.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.